EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors
EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors - a Pilot Study
University Medical Center Groningen
20 participants
Jul 2, 2025
INTERVENTIONAL
Conditions
Summary
To explore the effectiveness of EMDR therapy treatment in reducing symptoms of chemotherapy-induced conditioned nausea and vomiting in (former) patients with cancer.
Eligibility
Inclusion Criteria5
- Previously pathologically confirmed diagnosis of cancer
- Previously treated with systemic cancer therapy
- Persistent complaints (more than 2 months) of conditioned nausea and/or vomiting
- Able to understand spoken and written Dutch
- years or older
Exclusion Criteria4
- Ongoing psychiatric treatment
- EMDR therapy contraindications (dissociative disorders, personality disorders or severe somatic disorders (e.g. cardiac arrhythmias))
- Complex type 2 trauma
- Known with recent conditions / non-anti-cancer medication which can elicit nausea (e.g. pregnancy or alcohol abuses)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
In this study, EMDR therapy will be performed by psychologists of the UMCG who are trained in EMDR therapy and who have experience with patients with somatic diseases. In the EMDR therapy protocol, the patient is guided through eight phases which incorporate dual focus of attention and alternating bilateral visual, auditory, and/or tactile stimulation (see supplement for protocol). The number of sessions varies per patient (1-3 sessions), depending on the desensitization of the conditioned stimuli. The sessions will last 60-90 minutes.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06769165